These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 8919463)

  • 1. Evaluation of significance of AgNOR counts in differentiating benign from malignant lesions in the breast.
    Dube MK; Govil A
    Indian J Pathol Microbiol; 1995 Jan; 38(1):5-10. PubMed ID: 8919463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic relevance of silver stained nucleolar organizer region (AgNORs) in benign and malignant breast lesions.
    Agarwal PK; Mehrotra A; Chandra T
    Indian J Exp Biol; 1995 Oct; 33(10):715-20. PubMed ID: 8575800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of silver binding nucleolar organiser regions (AgNORs) of breast lesions in histological sections and fine needle aspiration smears.
    Basu A; Sanyal S; Bhattacharyya A; Bhattacharyya S; Dasgupta S
    J Indian Med Assoc; 1997 Aug; 95(8):443-7. PubMed ID: 9492450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.
    Hasnan J; Jayaram G
    Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argyrophilic staining for nucleolar organizer region (AgNOR). A suitable methodology for differential diagnosis of breast lesions?
    Sivrides E; Anastasiadis P; von Lüdinghausen M
    Zentralbl Pathol; 1992 Apr; 138(2):103-7. PubMed ID: 1610761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry.
    Giri DD; Nottingham JF; Lawry J; Dundas SA; Underwood JC
    J Pathol; 1989 Apr; 157(4):307-13. PubMed ID: 2715879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of AgNORS in fine needle aspiration cytology of breast lesions.
    Rajeevan K; Aravindan KP; Kumari BC
    Indian J Pathol Microbiol; 1995 Jan; 38(1):17-24. PubMed ID: 8919465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleolar organizer regions in human breast cancer.
    Roller E; Fritz P; Wicherek C; Klumpp B; Lauinger J; Mischlinski A; Wanner B; Schumacher K
    Zentralbl Pathol; 1993 Aug; 139(3):195-9. PubMed ID: 8218120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of argyrophylic nucleolar organiser regions (AgNORs) in breast lesions.
    Simha M; Menon M; Doctor V
    Indian J Cancer; 1996 Jun; 33(2):76-85. PubMed ID: 8979469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleolar organizer regions in breast cytology material.
    Rath-Wolfson L; Hamel I; Halpern M; Klein B; Gal R
    Acta Cytol; 1995; 39(5):852-7. PubMed ID: 7571959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between clinical staging, oestrogen receptor status and silver-binding nucleolar organiser regions (AgNOR) in breast carcinoma.
    Ohri AK; Ohri SK; Herbert A; Royle G; Taylor I
    Eur J Surg Oncol; 1992 Apr; 18(2):103-7. PubMed ID: 1582501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.
    Sacks NP; Robertson JF; Ellis IO; Nicholson RI; Crocker J; Blamey RW
    Eur J Surg Oncol; 1992 Apr; 18(2):98-102. PubMed ID: 1582518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of argyrophilic nucleolar organizer regions (AgNOR) and microvessel quantitation by staining for factor VIII-related antigen as prognostic indicators in stage I breast cancer].
    Ogawa Y; Chung YS; Nakata B; Takatsuka S; Maeda K; Sawada T; Kato Y; Yoshikawa K; Sowa M
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():66-70. PubMed ID: 7747994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of fixation and preparation on the AgNOR distribution in routinely processed breast cancer specimens.
    Biesterfeld S; Ruoss E; Hufnagl P; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):41-8. PubMed ID: 7515672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argyrophilic nucleolar organizer regions in soft tissue tumors.
    Arora HL; Arora N; Solanki RL
    Indian J Pathol Microbiol; 1996 Oct; 39(4):257-63. PubMed ID: 9009475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical significance of AgNOR counts in FNAC smears and corresponding histopathological sections.
    Mehrotra A; Chandra T
    Indian J Exp Biol; 1998 Feb; 36(2):162-6. PubMed ID: 9754045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar organizer regions in smooth muscle and breast tumours.
    Reddy GS; Sesikeran B; Bhaskaran CS
    Indian J Pathol Microbiol; 1992 Jul; 35(3):219-28. PubMed ID: 1344157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the utility of silver nucleolar organizer regions in categorization and prognosis of salivary gland tumors.
    Adeyemi BF; Kolude BM; Akang EE; Lawoyin JO
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):513-20. PubMed ID: 16997120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.